Real-World Data: Assessing Electronic Health Records and Medical Claims Data To Support Regulatory Decision-Making for Drug and Biological Products; Guidance for Industry
NonrulemakingOtherFDA-2020-D-2307-0067
Comments
2
Awaiting comments
Deadline
No comment period
Net support
+100%
Support minus oppose · campaigns included
+100% excluding campaigns
Document
Details
The document's own metadata, straight from regulations.gov.
- Posted
- Jul 25, 2024
- Comment period
- Jul 25, 2024 – ?
- Agency
- Food and Drug Administration (FDA)
Analysis
Overview
What the public is saying — stance, who's commenting, and the issues they raise.
Analyzed 2 of 2 comments
100%· analysis complete
Stance breakdown
+100%
Net support
Support2
Aggregates include form-letter campaigns. Excluding them, net support is +100% across organic comments.
Who commented
Breakdown by commenter type.
Individual
2
Comments over time
Weekly arrivals, stacked by stance.
Posted Jul 25, 2024
Support2Oppose0Other0
Support × commenter type
How each type splits across stance.
Issues raised
The docket's canonical issues. Select one to filter the Explorer.
Issues are identified as comment analysis progresses — nothing tagged on this document yet.
Comments
Explorer
Every mirrored comment — filter by stance, campaign, or issue.
Read all 2 comments
The Explorer — every comment with stance, commenter type, and AI summaries — is part of the paid plan. $180/month per seat, 30-day money-back guarantee.